AI-based predictive biomarker discovery via contrastive learning retrospectively improves clinical trial outcome
Etai Jacob(AstraZeneca (United States)), Kaitlin M. Smith(AstraZeneca (United States)), Gerald J. Sun(AstraZeneca (United States)), Damián E. Bikiel(AstraZeneca (United States)), Elly Kipkogei(AstraZeneca (United States)), Gustavo Arango-Argoty(AstraZeneca (South Korea))
Cited by 2
Related Papers
DeepARG: a deep learning approach for predicting antibiotic resistance genes from metagenomic data
|Microbiome|2018|962
An in-depth map of polyadenylation sites in cancer
|Nucleic Acids Research|2012|151
NanoARG: a web service for detecting and contextualizing antimicrobial resistance genes from nanopore-derived metagenomes
|Microbiome|2019|119
Demonstrating a Comprehensive Wastewater-Based Surveillance Approach That Differentiates Globally Sourced Resistomes
|Environmental Science & Technology|2022|85
DeepARG: A deep learning approach for predicting antibiotic resistance genes from metagenomic data
|bioRxiv (Cold Spring Harbor Laboratory)|2017|78